SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
-0.58%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$300M
AUM Growth
-$202M
(-40%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-70.9%
Top 10 Holdings %
Top 10 Hldgs %
37.39%
Holding
273
New
28
Increased
51
Reduced
62
Closed
72
Top Buys
| 1 |
Alkermes
ALKS
|
$10.5M |
| 2 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$6.24M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$6.16M |
| 4 |
United Therapeutics
UTHR
|
$5.45M |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$5.01M |
Top Sells
| 1 |
Biogen
BIIB
|
$22.9M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$18.3M |
| 3 |
Viatris
VTRS
|
$15.2M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$15M |
| 5 |
Edwards Lifesciences
EW
|
$11.7M |
Sector Composition
| 1 | Healthcare | 63.58% |
| 2 | Technology | 2.74% |
| 3 | Consumer Staples | 0.59% |
| 4 | Industrials | 0.54% |
| 5 | Materials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Carisma Therapeutics
CARM
$13.4M
| $584K | 0.03% |
9,702
+1,125
| +13% | +$67.7K |
|
102
Capricor Therapeutics
CAPR
$272M
| $570K | 0.03% |
18,566
-6,479
| -26% | -$199K |
|
|
REE
103
DELISTED
RARE ELEMENT RES LTD
REE
| $519K | 0.03% |
3,436,858
-407,015
| -11% | -$61.5K |
|
|
ALBO
104
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $507K | 0.03% |
49,358
+16,569
| +51% | +$170K |
|
|
SCON
105
DELISTED
Superconductor Technologies Inc.
SCON
| $493K | 0.03% |
1,567
+1,036
| +195% | +$326K |
|
|
VPCO
106
DELISTED
VAPOR CORP DEL COM STK
VPCO
| $487K | 0.03% |
+901,608
| New | +$487K |
|
|
107
Edwards Lifesciences
EW
$47.5B
| $482K | 0.03% |
18,321
-445,209
| -96% | -$11.7M |
|
|
SAGE
108
DELISTED
Sage Therapeutics
SAGE
| $474K | 0.03% |
8,123
-31,896
| -80% | -$1.86M |
|
109
Aldeyra Therapeutics
ALDX
$332M
| $466K | 0.03% |
68,699
-66,298
| -49% | -$450K |
|
|
CSLT
110
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $455K | 0.03% |
+106,500
| New | +$455K |
|
111
Esperion Therapeutics
ESPR
$510M
| $423K | 0.02% |
19,000
-4,990
| -21% | -$111K |
|
112
Ocugen
OCGN
$322M
| $412K | 0.02% |
1,961
+1,503
| +328% | +$316K |
|
|
AFMD
113
DELISTED
Affimed
AFMD
| $404K | 0.02% |
5,677
| – | – |
|
|
THMO
114
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
| $387K | 0.02% |
236
-153
| -39% | -$251K |
|
|
ALXN
115
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $373K | 0.02% |
1,956
-47,441
| -96% | -$9.05M |
|
116
Omeros
OMER
$284M
| $369K | 0.02% |
23,450
-18,927
| -45% | -$298K |
|
117
Seres Therapeutics
MCRB
$165M
| $368K | 0.02% |
525
-2,714
| -84% | -$1.9M |
|
118
ProQR Therapeutics
PRQR
$252M
| $346K | 0.02% |
39,871
+17,921
| +82% | +$156K |
|
119
Precigen
PGEN
$1.36B
| $331K | 0.02% |
+11,094
| New | +$331K |
|
120
MEI Pharma
MEIP
$140M
| $320K | 0.02% |
10,000
-4,775
| -32% | -$153K |
|
|
ZSAN
121
DELISTED
Zosano Pharma Corporation
ZSAN
| $287K | 0.02% |
184
-49
| -21% | -$76.4K |
|
|
HSTO
122
DELISTED
Histogen Inc. Common Stock
HSTO
| $254K | 0.01% |
441
+128
| +41% | +$73.7K |
|
123
Amicus Therapeutics
FOLD
$2.47B
| $249K | 0.01% |
+25,661
| New | +$249K |
|
|
APEN
124
DELISTED
Apollo Endosurgery, Inc.
APEN
| $249K | 0.01% |
14,375
+269
| +2% | +$4.66K |
|
125
uniQure
QURE
$973M
| $217K | 0.01% |
+13,131
| New | +$217K |
|